These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2476460)
1. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1). Döpel SH; Porstmann T; Henklein P; von Baehr R J Virol Methods; 1989 Aug; 25(2):167-77. PubMed ID: 2476460 [TBL] [Abstract][Full Text] [Related]
2. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates. Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985 [TBL] [Abstract][Full Text] [Related]
3. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. Neurath AR; Strick N; Lee ES J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372 [TBL] [Abstract][Full Text] [Related]
4. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein. Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436 [TBL] [Abstract][Full Text] [Related]
5. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA. Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841 [TBL] [Abstract][Full Text] [Related]
6. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera. Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754 [TBL] [Abstract][Full Text] [Related]
7. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus. Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470 [TBL] [Abstract][Full Text] [Related]
8. Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice. Lombardi V; Placido R; Scarlatti G; Romiti ML; Mattei M; Mariani F; Poccia F; Rossi P; Colizzi V J Infect Dis; 1993 Jun; 167(6):1267-73. PubMed ID: 7684755 [TBL] [Abstract][Full Text] [Related]
9. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215 [TBL] [Abstract][Full Text] [Related]
10. Epitope contiguous chains and antibody recognition in HIV-1 synthetic peptide antigens. Aleanzi M; Perotti N; Montaner A; Lottersberger J; Tonarelli G; Marcipar A J Mol Recognit; 1996; 9(5-6):631-8. PubMed ID: 9174949 [TBL] [Abstract][Full Text] [Related]
11. Antibodies against a peptide sequence within the HIV envelope protein crossreacts with human interleukin-2. Bost KL; Pascual DW Immunol Invest; 1988; 17(6-7):577-86. PubMed ID: 2466783 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of gp41 antigens by enzyme-linked immunosorbent assays for detecting antibodies to human immunodeficiency virus type 1. Zweig M; Bladen SV; Dubois GC; Samuel KP; Showalter SD; Papas TS AIDS Res Hum Retroviruses; 1988 Dec; 4(6):487-92. PubMed ID: 3265329 [TBL] [Abstract][Full Text] [Related]
13. The use of multiple antigenic peptide (MAP) in the immunodiagnosis of human immunodeficiency virus infection. Shin SY; Lee MK; Kim SY; Jang SY; Hahm KS Biochem Mol Biol Int; 1997 Nov; 43(4):713-21. PubMed ID: 9385431 [TBL] [Abstract][Full Text] [Related]
14. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1. Madaule P; Gairin JE; Bénichou S; Rossier J FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777 [TBL] [Abstract][Full Text] [Related]
15. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein. Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197 [TBL] [Abstract][Full Text] [Related]
16. Binding behaviour of antibodies reacting specifically with an immunodominant region of the transmembrane protein gp41 of HIV-1. Döpel SH; Porstmann T; Grunow R; Henklein P; Pas P; von Baehr R J Virol Methods; 1990 May; 28(2):189-98. PubMed ID: 1695222 [TBL] [Abstract][Full Text] [Related]
17. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection. Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821 [TBL] [Abstract][Full Text] [Related]
18. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41. Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration. D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. McLain L; Durrani Z; Wisniewski LA; Porta C; Lomonossoff GP; Dimmock NJ Vaccine; 1996 Jun; 14(8):799-810. PubMed ID: 8817828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]